| Primary |
| Product Used For Unknown Indication |
26.9% |
| Anaemia |
22.0% |
| Hypoparathyroidism |
9.9% |
| Hypocalcaemia |
7.0% |
| Hypothyroidism |
4.6% |
| Drug Use For Unknown Indication |
4.0% |
| Osteoporosis |
3.0% |
| Hypertension |
2.7% |
| Hyperparathyroidism Secondary |
2.4% |
| Rickets |
2.4% |
| Heart Transplant |
2.2% |
| Hyperparathyroidism |
2.2% |
| Refractory Anaemia With An Excess Of Blasts |
2.2% |
| Nephrogenic Anaemia |
1.9% |
| Rheumatoid Arthritis |
1.3% |
| Hyperphosphataemia |
1.1% |
| Prophylactic Chemotherapy |
1.1% |
| Prostate Cancer |
1.1% |
| Prostate Cancer Recurrent |
1.1% |
| Renal Failure Chronic |
1.1% |
|
| Hypercalcaemia |
16.8% |
| Acute Myeloid Leukaemia |
9.5% |
| Cardiovascular Disorder |
8.4% |
| Nephrolithiasis |
6.3% |
| Renal Failure |
6.3% |
| Transplant Rejection |
6.3% |
| Milk-alkali Syndrome |
5.3% |
| Renal Failure Acute |
5.3% |
| Vomiting |
4.2% |
| Abdominal Pain |
3.2% |
| Adverse Event |
3.2% |
| Coma |
3.2% |
| Death |
3.2% |
| Neoplasm Malignant |
3.2% |
| Syncope |
3.2% |
| Urinary Tract Infection |
3.2% |
| Weight Decreased |
3.2% |
| Blood Calcium Decreased |
2.1% |
| Calciphylaxis |
2.1% |
| Drug Effect Decreased |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
29.3% |
| Drug Use For Unknown Indication |
18.7% |
| Hypocalcaemia |
6.7% |
| Hypertension |
5.4% |
| Anaemia |
4.9% |
| Hypoparathyroidism |
4.4% |
| Calcium Deficiency |
4.1% |
| Dementia Alzheimer's Type |
2.3% |
| Heart Transplant |
2.3% |
| Hypothyroidism |
2.3% |
| Pustular Psoriasis |
2.3% |
| Acute Lymphocytic Leukaemia |
2.1% |
| Blood Parathyroid Hormone |
2.1% |
| Depression |
2.1% |
| Osteoporosis |
2.1% |
| Refractory Anaemia With An Excess Of Blasts |
2.1% |
| Hyperphosphataemia |
1.8% |
| Prophylaxis Against Transplant Rejection |
1.8% |
| Arthritis |
1.6% |
| Renal Failure Chronic |
1.6% |
|
| Acute Myeloid Leukaemia |
11.4% |
| Cardiovascular Disorder |
10.1% |
| Milk-alkali Syndrome |
10.1% |
| Nephrocalcinosis |
7.6% |
| Calciphylaxis |
6.3% |
| Weight Increased |
6.3% |
| Wheezing |
6.3% |
| Adverse Event |
5.1% |
| Hypercalcaemia |
5.1% |
| Death |
3.8% |
| Iron Deficiency Anaemia |
3.8% |
| Nephrolithiasis |
3.8% |
| Angioedema |
2.5% |
| Dizziness |
2.5% |
| Haemolytic Anaemia |
2.5% |
| Infection |
2.5% |
| Neoplasm Malignant |
2.5% |
| Osteoporosis |
2.5% |
| Pain |
2.5% |
| Prostate Cancer |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.7% |
| Drug Use For Unknown Indication |
29.3% |
| Hypertension |
6.2% |
| Rheumatoid Arthritis |
5.0% |
| Nuclear Magnetic Resonance Imaging |
3.0% |
| Renal Failure Chronic |
3.0% |
| Peritoneal Dialysis |
2.9% |
| Osteoporosis |
2.8% |
| Prophylaxis |
2.7% |
| Pain |
2.3% |
| Renal Transplant |
1.9% |
| Diabetes Mellitus |
1.6% |
| Hyperparathyroidism Secondary |
1.5% |
| Anaemia |
1.2% |
| Depression |
1.2% |
| Prostate Cancer |
1.1% |
| Crohn's Disease |
1.0% |
| Dialysis |
0.9% |
| Type 2 Diabetes Mellitus |
0.9% |
| Multiple Myeloma |
0.9% |
|
| Vomiting |
21.1% |
| Weight Decreased |
7.1% |
| Pyrexia |
6.0% |
| Therapeutic Response Decreased |
5.3% |
| Pneumonia |
5.2% |
| Renal Failure |
5.1% |
| Renal Failure Acute |
5.1% |
| Death |
4.5% |
| Peritonitis Bacterial |
4.3% |
| Skin Tightness |
4.0% |
| Haemoglobin Decreased |
3.9% |
| Urinary Tract Infection |
3.7% |
| Diarrhoea |
3.5% |
| Wheezing |
3.5% |
| Renal Failure Chronic |
3.1% |
| Drug Ineffective |
3.0% |
| Nephrogenic Systemic Fibrosis |
3.0% |
| Sepsis |
3.0% |
| Urticaria |
3.0% |
| Renal Impairment |
2.9% |
|
| Interacting |
| Bk Virus Infection |
100.0% |
|
|
